4E-BP1 has been extensively studied and its expression and phosphorylation levels have been used as surrogate markers of tumour malignancy in preclinical17, 19, 43 and clinical settings20, 23, 62, 63. The gene discussed is EIF4EBP1; the disease is neoplasm.